Considerations For Complex Formulations – How To Simplify Your Outsourcing


While technology transfers can be a challenge with any drug product, even greater vigilance is needed with more complex formulations such as lipid nanoparticle-based (LNPs) drugs. These complex formulations have structural similarities to naturally occurring biological vehicles; as a result, they are generally well tolerated by the body. Therefore, LNPs are increasingly being used to deliver highly specialized therapeutics molecules, such as oligonucleotides, which are seeing heightened attention in drug development due to their ability to tackle disease on the genetic level.

Despite the growing body of research and scientific knowledge, LNP formulations are inherently complex and require a more comprehensive manufacturing and testing approach. The stability profile of the finished formulation is very dependent on lipid selection and the manufacturing process. Many involve novel payloads or APIs, and interactions between the various compendial raw materials are not fully understood.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online

Ajinomoto Bio-Pharma Services